T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers Meeting Abstract


Authors: Ma, J.; Klatt, M.; Dundar, F.; Zumbo, P.; Femia, M.; Betel, D.; Scheinberg, D.; Baker, B.; Klebanoff, C.; Chandran, S.
Abstract Title: T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
Meeting Title: 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 7
Issue: Suppl. 1
Meeting Dates: 2019 Nov 6-10
Meeting Location: National Harbor, MD
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2019-11-01
Start Page: 282
Language: English
ACCESSION: WOS:000496473200595
PROVIDER: wos
PMCID: PMC6833189
PUBMED: 31694725
DOI: 10.1186/s40425-019-0763-1
Notes: Meeting Abstract: P171 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Doron Betel
    10 Betel
  2. Martin Gunther Klatt
    8 Klatt
  3. Matthew R Femia
    3 Femia